| P50 | author | Merryn Voysey | Q42688630 |
| | Matthew D Snape | Q55456266 |
| | Jason Hinds | Q60983251 |
| | Andrew J. Pollard | Q64861148 |
| | David Murdoch | Q88255291 |
| P2093 | author name string | Usha Kiran | |
| | Dominic F Kelly | |
| | Sarah Kelly | |
| | Santosh Gurung | |
| | Neelam Adhikari | |
| | Shrijana Shrestha | |
| | Stephen Thorson | |
| | Meeru Gurung | |
| | Rama Kandasamy | |
| | Fiona van der Klis | |
| | Mainga Hamaluba | |
| | Rahul Pradhan | |
| | Rakesh Maharjan | |
| | Shachi Pradhan | |
| | Shyam R Upreti | |
| | Simon A Kerridge | |
| | Anushil K Thapa | |
| | Giri R Subedi | |
| | Shiva Bhattarai | |
| P2860 | cites work | Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates | Q28258300 |
| | Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation | Q33721628 |
| | Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study | Q33869370 |
| | A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Ma | Q34867264 |
| | Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae | Q37212564 |
| | Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity | Q37613613 |
| | Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis | Q37912703 |
| | Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: a systematic review and meta-analysis | Q37935977 |
| | Effectiveness of 2+1 PCV7 vaccination schedules in children under 2 years: a meta-analysis of impact studies | Q38154354 |
| | Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial. | Q38445205 |
| | The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity | Q38905558 |
| | Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay | Q39507980 |
| | The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal | Q39961046 |
| | Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial | Q42286179 |
| | Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network | Q43611429 |
| | Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine: a randomized controlled trial | Q44043602 |
| | Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands | Q44549561 |
| | Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. | Q53008392 |
| | Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers | Q77838494 |
| | Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized co | Q83843619 |
| | The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial | Q84344058 |
| P433 | issue | 4 | |
| P921 | main subject | pneumococcal conjugate vaccine | Q7205991 |
| | Nepal | Q837 |
| P304 | page(s) | 405-414 | |
| P577 | publication date | 2015-02-18 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial | |
| P478 | volume | 15 | |